Evidence map›Paper›PMID 31485206›Full record

ReviewPrzeglad menopauzalny = Menopause review2019

Blood pressure in postmenopausal women with a history of polycystic ovary syndrome.

Katarzyna Doroszewska, Tomasz Milewicz, Sandra Mrozińska, Jarosław Janeczko, Radosław Rokicki, Marek Janeczko, Damian Warzecha, Piotr Marianowski

Open access · goldAbstract readReview
In one paragraph

Review in Przeglad menopauzalny = Menopause review, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. The role of androgen and its related signals in PCOS.Journal of cellular and molecular medicine · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Katarzyna DoroszewskaDepartment of Gynaecological Endocrinology and Gynaecology, Jagiellonian University Medical College, Cracow, Poland.
Tomasz MilewiczDepartment of Gynaecological Endocrinology and Gynaecology, Jagiellonian University Medical College, Cracow, Poland.
Sandra MrozińskaDepartment of Metabolic Diseases, Jagiellonian University Medical College, Cracow, Poland.
Jarosław JaneczkoInfertility Treatment Centre PARENS, Cracow, Poland.
Radosław RokickiInfertility Treatment Centre PARENS, Cracow, Poland.
Marek JaneczkoInfertility Treatment Centre PARENS, Cracow, Poland.
Damian Warzecha1 Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland.
Piotr Marianowski1 Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland.
Jagiellonian University · PLStem Cells Spin (Poland) · PLMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder at reproductive age, affecting 6-10% of females in this group. The aetiology of this syndrome is not fully understood. Genetics, endocrinology factors, and the influence of the environment are possible causes of this syndrome. PCOS is characterised by menstrual disorders, hyperandrogenism, and abnormalities in ovarian morphology as well as metabolic disorders. PCOS increases the risk of overweight and obesity, diabetes, endometrial cancer, and cardiovascular diseases such as hypertension along with all its long-term consequences. There are limited studies about cardiovascular disorders, especially hypertension, in postmenopausal women with a history of PCOS. The presented paper is an attempt to briefly summarise literature data concerning the influence of this disease on the incidence of hypertension and blood pressure control in postmenopausal women. Women with PCOS more often present features of metabolic syndrome and have increased cardiovascular risk factors including hypertension. The prevalence of hypertension is 2.5 times higher than in corresponding healthy peers. Furthermore, hyperandrogenaemia is associated with elevated blood pressure independent of the patient's age, insulin resistance, obesity, and dyslipidaemia. In view of this, these patients should be thoroughly screened for hypertensive disorders and educated about the lifestyle modifications that could prevent hypertension later in life.

Indexed as

blood pressurehyperandrogenaemiahypertensionmenopausepolycystic ovary syndrome

Identifiers

PMID31485206
PMCPMC6719632
OpenAlexW2954112766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.